REGEN-COV and COVID-19, update on the drug profile and FDA status: A mini-review and bibliometric study

REGEN-COV and COVID-19, update on the drug profile and FDA status: A mini-review and bibliometric study

COVID-19 is caused by coronavirus (SARS-CoV-2) is a worldwide health crisis. This severe acute respiratory syndrome was declared an outbreak after the first case was reported in Wuhan, the capital city of Hubei Province in China. On March 11th, 2020, the World Health Organization (WHO) declared it...

Full description

Bibliographic Details
Main Authors: Saeid Mezail Mawazi, Jiyauddin Khan, Noordin Othman, Sultan Othman Alolayan, Yaser M. Alahmadi, Sultan S. Al Thagfan, Sally A. Helmy, Roy Rillera Marzo
Format: Article
Language:English
Published: SAGE Publishing 2022-03-01
Series:Journal of Public Health Research
Subjects:
REGEN-COV
casirivimab and imdevimab
COVID-19
SARS-CoV-2
Ronapreve
Online Access:https://www.jphres.org/index.php/jphres/article/view/2930

Similar Items

Similar Items